Next-Generation Ultrasound-Mediated Brain Therapies
Legal Citation
Summary of the Inventive Concept
A revolutionary platform integrating wearable ultrasound devices, micro-robotic delivery systems, and AI-powered neural interfaces to non-invasively deliver therapeutics across the blood-brain barrier, enabling personalized treatment of brain disorders and unlocking new possibilities for cognitive enhancement and gene editing.
Background and Problem Solved
The original patent, 'Ultrasound guided opening of blood-brain barrier,' introduced a groundbreaking approach to delivering drugs to the brain. However, its limitations in terms of invasiveness, targeting, and real-time monitoring necessitate a next-generation solution. The new inventive concept addresses these limitations by introducing wearable, micro-robotic, and AI-powered components to enable more precise, adaptive, and non-invasive treatments.
Detailed Description of the Inventive Concept
The next-generation platform consists of a wearable ultrasound device, a micro-robotic delivery system, and an AI-powered neural interface. The wearable ultrasound device emits focused ultrasound pulses at target regions of the brain, while the micro-robotic delivery system injects therapeutic agents into the bloodstream in synchronization with the ultrasound pulses. The AI-powered neural interface provides real-time monitoring of brain activity and adaptive control of the ultrasound pulses. This integrated system enables personalized blood-brain barrier opening, ultrasound-mediated gene editing, and non-invasive brain-computer interfaces.
Novelty and Inventive Step
The new inventive concept introduces a paradigm shift in ultrasound-mediated brain therapies by integrating wearable, micro-robotic, and AI-powered components. The inventive step lies in the combination of these components to enable non-invasive, adaptive, and personalized treatments, which overcome the limitations of the original patent and provide a new generation of possibilities for brain therapy and enhancement.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include implantable ultrasound transducer arrays, neural prosthetic devices, or transcranial ultrasound devices. Variations could involve different types of therapeutic agents, gene editing modules, or AI-powered control systems. These alternatives and variations ensure broad conceptual coverage and potential for further innovation.
Potential Commercial Applications and Market
The next-generation ultrasound-mediated brain therapies platform has significant commercial potential in the pharmaceutical, biotechnology, and medical device industries. Target markets include treatment of brain disorders, cognitive enhancement, and gene editing, with potential for expansion into new areas such as non-invasive brain-computer interfaces and personalized medicine.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering, ultrasound-based medical interventions, neurological treatment technologies with expertise in transducer design, robotic manipulation, and blood-brain barrier targeting techniques
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device researcher with advanced degrees in bioengineering, experience in ultrasound technologies, neural interface design, and familiarity with minimally invasive brain treatment methodologies
Obviousness Rationale
A PHOSITA would recognize that the published technical disclosure represents a predictable extension of the source patent's ultrasound-guided blood-brain barrier opening technique by integrating known technological components like micro-robotic systems, AI-powered neural interfaces, and adaptive targeting methodologies. The core ultrasound transducer principles remain consistent, with the primary innovation being the systematic combination of existing technological approaches to enhance precision and personalization of brain therapeutic interventions.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,812 |
|---|---|
| Title | Ultrasound guided opening of blood-brain barrier |
| Assignee(s) | Cordance Medical Inc. |